PL2310020T3 - Nowe octany 2-deoksymonosacharydów o aktywności przeciwnowotworowej - Google Patents

Nowe octany 2-deoksymonosacharydów o aktywności przeciwnowotworowej

Info

Publication number
PL2310020T3
PL2310020T3 PL09794965T PL09794965T PL2310020T3 PL 2310020 T3 PL2310020 T3 PL 2310020T3 PL 09794965 T PL09794965 T PL 09794965T PL 09794965 T PL09794965 T PL 09794965T PL 2310020 T3 PL2310020 T3 PL 2310020T3
Authority
PL
Poland
Prior art keywords
acetates
novel
anticancer activity
deoxy
monosaccharides
Prior art date
Application number
PL09794965T
Other languages
English (en)
Polish (pl)
Inventor
Waldemar Priebe
Marcin Cybulski
Izabela Fokt
Stainslaw Skora
Charles Conrad
Timothy Madden
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of PL2310020T3 publication Critical patent/PL2310020T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PL09794965T 2008-07-11 2009-06-25 Nowe octany 2-deoksymonosacharydów o aktywności przeciwnowotworowej PL2310020T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7996808P 2008-07-11 2008-07-11
EP09794965.5A EP2310020B1 (en) 2008-07-11 2009-06-25 Novel acetates of 2-deoxy monosaccharides with anticancer activity
PCT/US2009/048675 WO2010005799A2 (en) 2008-07-11 2009-06-25 Novel acetates of 2-deoxy monosaccharides with anticancer activity

Publications (1)

Publication Number Publication Date
PL2310020T3 true PL2310020T3 (pl) 2017-10-31

Family

ID=41507670

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09794965T PL2310020T3 (pl) 2008-07-11 2009-06-25 Nowe octany 2-deoksymonosacharydów o aktywności przeciwnowotworowej

Country Status (10)

Country Link
US (1) US8927506B2 (enExample)
EP (1) EP2310020B1 (enExample)
JP (2) JP5677951B2 (enExample)
CN (1) CN102149388B (enExample)
DK (1) DK2310020T3 (enExample)
ES (1) ES2628180T3 (enExample)
HU (1) HUE033210T2 (enExample)
LT (1) LT2310020T (enExample)
PL (1) PL2310020T3 (enExample)
WO (1) WO2010005799A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9149489B2 (en) 2006-04-27 2015-10-06 Board Of Regents, University Of Texas System Inhibitors of glycolysis useful in the treatment of brain tumors
ES2628180T3 (es) 2008-07-11 2017-08-02 Board Of Regents, The University Of Texas System Nuevos acetatos de 2-desoxi monosacáridos con actividad anticancerosa
JP2014505058A (ja) * 2011-01-11 2014-02-27 ザ・ユニバーシティ・オブ・テキサス・エム・ディー・アンダーソン・キャンサー 増殖性および炎症性皮膚疾患の治療用単糖ベース化合物
WO2012142615A2 (en) * 2011-04-14 2012-10-18 Board Of Regents, The University Of Texas System Auranofin and auranofin analogs useful to treat proliferative disease and disorders
CA2870248A1 (en) * 2012-04-12 2013-10-17 Gifu University Medicinal composition for treating infarction
EP3939595A1 (en) 2013-04-05 2022-01-19 Board of Regents, The University of Texas System Esters of 2-deoxy-monosaccharides with anti proliferative activity
WO2020035782A1 (en) * 2018-08-13 2020-02-20 Dermin Sp. Z O.O. Molecular probes for analysis of metabolism of glycolysis inhibitors prodrugs and synthesis methods therefore
EP4121060A1 (en) 2020-03-16 2023-01-25 Board of Regents, The University of Texas System Method of treating viral infections with hexose type monosaccharides and analogs thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56103197A (en) 1980-01-21 1981-08-18 Wakamoto Pharmaceut Co Ltd Novel d-glucose derivative and antitumor agent containing the same as active constitutent
JPS58167582A (ja) 1982-03-29 1983-10-03 Takeda Chem Ind Ltd 糖ケタ−ルの製造法
US6319695B1 (en) 1991-10-15 2001-11-20 The Scripps Research Insitute Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose
IL122700A0 (en) 1995-06-23 1998-12-06 Oxford Glycosciences Uk Ltd Pyranosyl conjugates for delivery of active moieties
EE200200565A (et) 2000-03-31 2004-06-15 Angiogene Pharmaceuticals Ltd. Vaskulaarse kahjustava toimega kombinatsioonravi
US6670330B1 (en) 2000-05-01 2003-12-30 Theodore J. Lampidis Cancer chemotherapy with 2-deoxy-D-glucose
US6894033B2 (en) 2001-06-11 2005-05-17 Transition Therapeutics Inc. Combination therapies using vitamin B12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases
WO2003018598A2 (en) 2001-08-30 2003-03-06 University College Dublin Monosaccharide derivatives
US7001888B2 (en) 2002-03-29 2006-02-21 Threshold Pharmaceuticals, Inc. Compositions and methods for treating cancer
US6979675B2 (en) * 2003-01-10 2005-12-27 Threshold Pharmaceuticals, Inc. Treatment of cancer with 2-deoxyglucose
CA2431425A1 (en) 2003-06-05 2004-12-05 Angiogene, Inc. Epas1 gene transfer to improve cell therapy
US20050143336A1 (en) 2003-12-30 2005-06-30 Board Of Regents, The University Of Texas System Methods and compositions for improved non-viral gene therapy
EP1789107B1 (en) 2004-08-30 2009-05-27 Interstitial Therapeutics Medical stent provided with inhibitors of atp synthesis
WO2007101148A2 (en) 2006-02-24 2007-09-07 Board Of Regents, The University Of Texas System Hexose compounds to treat cancer
US8242167B2 (en) 2006-02-24 2012-08-14 University Of Miami Mannose derivatives for killing tumor cells
US9149489B2 (en) 2006-04-27 2015-10-06 Board Of Regents, University Of Texas System Inhibitors of glycolysis useful in the treatment of brain tumors
EP1881000A1 (en) * 2006-07-17 2008-01-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Conjugates of 2-fluoro-2-deoxy-glucose and their uses as anti cancer agents
WO2008131024A1 (en) 2007-04-17 2008-10-30 Board Of Regents, The University Of Texas System Iodo-hexose compounds useful to treat cancer
ES2628180T3 (es) 2008-07-11 2017-08-02 Board Of Regents, The University Of Texas System Nuevos acetatos de 2-desoxi monosacáridos con actividad anticancerosa
WO2012142615A2 (en) 2011-04-14 2012-10-18 Board Of Regents, The University Of Texas System Auranofin and auranofin analogs useful to treat proliferative disease and disorders

Also Published As

Publication number Publication date
HUE033210T2 (hu) 2017-11-28
LT2310020T (lt) 2017-07-25
JP5677951B2 (ja) 2015-02-25
EP2310020B1 (en) 2017-03-15
ES2628180T3 (es) 2017-08-02
EP2310020A2 (en) 2011-04-20
JP5890043B2 (ja) 2016-03-22
CN102149388A (zh) 2011-08-10
EP2310020A4 (en) 2012-04-25
WO2010005799A3 (en) 2010-04-29
US20110160151A1 (en) 2011-06-30
US8927506B2 (en) 2015-01-06
CN102149388B (zh) 2014-11-05
JP2015091849A (ja) 2015-05-14
WO2010005799A2 (en) 2010-01-14
JP2011527678A (ja) 2011-11-04
DK2310020T3 (en) 2017-06-26

Similar Documents

Publication Publication Date Title
GB2487497B (en) Sensor assembly with filter
IL216639A0 (en) Catheter with single axial sensors
SMT201700309T1 (it) Derivati di chinolin–8–solfonammide aventi un’attività anticancro
GB0902231D0 (en) Catayst
LT2310020T (lt) Nauji 2-deoksi monosacharidų acetatai, turintys priešvėžinį poveikį
EP2245148A4 (en) CELLULASE VARIANTS HAVING GLUCOSE-REDUCED INHIBITION
PL2473518T3 (pl) Stabilizowane ligandy melanokortyny
PL2504445T3 (pl) Fermentacja węglowodanu
EP2407711A4 (en) NUT-SHAPED LED
GB0906004D0 (en) MusicStation desktop
GB201300934D0 (en) Piezoresistive transducer with low thermal noise
EP2616548A4 (en) NANODEAGGREGATED CELLULOSE
GB0920013D0 (en) Glucose sensor
IL214022A0 (en) Melanocortin analogs with antimicrobial activity
GB201016767D0 (en) Furniture assembly
ZA201107541B (en) An enzyme with a-glucuronidase activity
TWM387880U (en) Architecture structure combined with bamboo
HU0900269D0 (en) Synhesis of carbohydrate n-conjugates with bh3-pyridine complex catalyst
TWI348442B (en) Convenience food structure
GB0813376D0 (en) Engine supreme
TWM372162U (en) Structure improvement of steamer
TWM389197U (en) Lollipop structure with recognizable illumination
TWM389196U (en) Lollipop structure with recognizable illumination
EG26816A (en) Continuous sugar jug
TWM365709U (en) Improved structure of magnetic-conductive cooker